Accuray (ARAY) Intangibles (2011 - 2026)

Accuray (ARAY) posted quarterly Intangibles of $13.5 million for Q1 2026, up 3.45% quarter-over-quarter from $13.1 million in Q4 2025.

Accuray (ARAY) Intangibles (2011 - 2026) Analysis & Trends

Accuray's Intangibles history runs 16 years deep, the most recent figure standing at $13.5 million for Q1 2026.

In Q1 2026, Intangibles changed N/A year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $13.5 million (changed N/A YoY), while the FY2025 annual figure was $10.3 million, up 17276.27% from the prior year.
Intangibles for Q1 2026 stood at $13.5 million, up from $13.1 million in the prior quarter.
The five-year high for Intangibles was $13.5 million in Q1 2026, with the low at $4000.0 in Q3 2025.
The 5-year median for Intangibles is $257000.0 (2023), against an average of $2.7 million.
The sharpest annual moves came in 2024 and 2025: Intangibles slumped 94.79% in 2024, then jumped 17276.27% in 2025.
Accuray's Intangibles stood at $268000.0 in 2022, then sank by 56.72% to $116000.0 in 2023, then plunged by 58.62% to $48000.0 in 2024, then jumped by 27145.83% to $13.1 million in 2025, then increased by 3.45% to $13.5 million in 2026.
Business Quant data shows ARAY's Intangibles at $13.5 million in Q1 2026, $13.1 million in Q4 2025, and $4000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	17.21 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	5.74 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	10.15 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	6.92 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	1.38 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	101.60 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	1.89 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	2.98 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.56 Bn
10	Accuray	35.97 Mn	-3.73 Mn	25.29 Mn	13.53 Mn

Download Data